Biomarkers

The Biomarker Revolution in Medicine and Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

Diagnostics

Better Outcomes for Cancer Patients Begin with Screening

BCAL DIagnostics

Partnerships

University-Industry Partnerships Tackling Genetic Disease Therapies and Diagnostic Innovation

Avicena Systems

Diagnostics

Avicena Systems' Cutting-Edge Biopreparedness and Testing Platform

Avicena Systems

Oncology

Up Close and Personal with Scientists on the Cutting Edge of Melanoma Research

Olivia Newton-John Cancer Research Institute

Exposomics

Transforming Precision Medicine through a High-Resolution Temporal Exposome Platform

Manish Arora, Ph.D.

LinusBio

Neurology

The Next Frontier in Neurological Diagnostics and Therapeutics

Dave Rosa

NeuroOne

Exosomes

Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Point of Care

Expanding Point-of-Care and CME Support for Clinicians

Casey Jenkins

epocrates

Point of Care

Helping Clinicians Make Better Decisions More Easily

Matt Titus

epocrates

Digital Health Solutions

Beyond Drug Sales: Adding Value with Digital Health

Gérard Klop; Marcos Gallego Llorente, Ph.D.

Theranostics

Theranostic Manufacturing Solutions

Muctarr Sesay, Ph.D.

GBI

Genomics

Connecting Genetic Mutations to Health

Heligenics

Biosensors

Exploring Living Cells with Fluorescent Biosensors

Montana Molecular

Brain Cancer Diagnostics

Advancing Diagnostics to Address Brain Tumors

Dxcover